Utente:Gianreali/prova 12

Da Wikipedia, l'enciclopedia libera.
Vai alla navigazione Vai alla ricerca
Nanosomi convenzionali (non stabilizzati) Nanosomi non pegilati (stabilizzati) Nanosomi pegilati (stabilizzati) Nanoparticelle Coniugati e polimeri Dendrimeri SMEDDS Microelectromechanical Systems (MEMS) Nanodiamonds
LE-SN38 (irinotecan) Optisoma TM topotecan Doxil AbraxaneTM (paclitaxel protein-bound particles) XyotaxTM (paclitaxel) G5-FA-MTX[1] SMEDDS- simvastatina doxorubicina[2]
Lurtotecan/OSI-211 Optisoma TM vincristina S-CKD602 Paclimer MER-1001 (rilascia camptothecin) dendrimeri (paclitaxel)[3] SMEDDS- vimpocetina
9NC Optisoma TM vinorelbine IHL-305 TocosolTM IT-101 (camptothecin coniugata con ciclodestrina)
Irinotecan ATI-1123[PSN (Protein Statabilized Nanoparticles)- Docetaxel] Nanoliposomal CPT-111 APA-thalidomide = microcapsule di Alginate-poly-l- lysine-alginate[4] DHA-paclitaxel
LEP-ETU (paclitaxel) ATI-1150 (campotecina) PX-NP (paclitaxel) PEGilated doxorubicina
Docetaxel NK-012 PEGilated methotrexate
Doxorubicina NK-105 (paclitaxel) PEGilated interferon
Daunorubicina ANX-514 (docetaxel) PEGilated camptothecin
Citarabina CNF1010 ENZ-2208
Topotecan albendazole polibutilcianocrilato (ABZ-PBCA-NP)[5] NKTR-102
Peg-irinotecan
FRL-doxorubicina:vincristina 20-carbonate-CTP
FRL-daunorubicina:citarabina PL-ara-C
FRL-floxuredina:irinotecan PL-gemcitabina
FRL-cisplatino:irinotecan CT-2116 (campotecina)
DACH L-NDDP AR-726 (analogo dell'oxaliplatino) AP 5286 (analogo del cisplatino HPMA)
MBP-426 (oxaliplatino) AP-5280 (analogo del cisplatino HPMA)

Note[modifica | modifica wikitesto]

  1. ^ Myc A, Douce TB, Ahuja N, Kotlyar A, Kukowska-Latallo J, Thomas TP, Baker JR Jr., Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates, Anticancer Drugs. 2008 Feb;19(2):143-9.
  2. ^ Houjin Huang, Erik Pierstorff, Eiji Osawa,Dean Ho, Nano Lett., 7 (11), 3305 -3314, 2007. 10.1021/nl071521o [1]
  3. ^ Lim J, Simanek EE.,Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel groups,Org Lett. 2008 Jan 17;10(2):201-4. Epub 2007 Dec 19.
  4. ^ Ma X, Vacek I, Sun A., Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions, Artif Cells Blood Substit Immobil Biotechnol. 1994;22(1):43-69
  5. ^ Xue-nong Zhang, Qiang Zhang, Hao Wen, Guo-quan Wang, Dian-jia Sun,Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution, Yao Xue Xue Bao. Jun;38 (6):462-6, 2003

.